4//SEC Filing
Shanler Stuart 4
Accession 0001209191-18-007464
CIK 0001557746other
Filed
Feb 4, 7:00 PM ET
Accepted
Feb 5, 4:21 PM ET
Size
8.0 KB
Accession
0001209191-18-007464
Insider Transaction Report
Form 4
Shanler Stuart
Chief Scientific Officer
Transactions
- Award
Stock option (right to buy)
2018-02-01+54,000→ 54,000 totalExercise: $22.09Exp: 2028-01-31→ Common Stock (54,000 underlying) - Award
Restricted stock units
2018-02-01+15,500→ 15,500 total→ Common Stock (15,500 underlying)
Footnotes (3)
- [F1]The option will vest over a period of four years, with 25% of the shares underlying the option vesting on the first, second, third and fourth anniversaries of the date of grant.
- [F2]Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.
- [F3]The shares underlying these restricted stock units vest in four equal annual installments beginning on February 1, 2019, subject to the reporting person's continuous service with the issuer as of the applicable vesting date.
Documents
Issuer
Aclaris Therapeutics, Inc.
CIK 0001557746
Entity typeother
Related Parties
1- filerCIK 0001654332
Filing Metadata
- Form type
- 4
- Filed
- Feb 4, 7:00 PM ET
- Accepted
- Feb 5, 4:21 PM ET
- Size
- 8.0 KB